Please Wait.....
Report
Australia Lung Cancer Screening Market Forecast to 2030 - COVID-19 Impact and Country Analysis by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
Market Report I 2023-07-04 I 127 Pages I The Insight Partners
The Australia lung cancer screening market size is expected to grow from US$ 2.74 million in 2022 to US$ 6.12 million by 2030; it is estimated to record a CAGR of 10.6% from 2022 to 2030.
The Australia lung cancer screening market growth is attributed to the increasing Incidence of lung cancer and rising government support. However, uncertainties related to lung cancer screening trial with LDCT is hampering the growth of the Australia lung cancer screening market.
Lung cancer screening is a process used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are long time smokers and who don't have any signs or symptoms of lung cancer. Doctors use a LDCT scan of the lungs to look for lung cancer. If lung cancer is detected early, it's more likely to be cured with treatment.
Structured Lung Cancer Screening Program is expected to provide the opportunities in the forecast period.
Australia faces unique challenges with lung cancer screening programs. A few examples of population-based Australian screening programs are "BreastScreen," the "National Bowel Cancer Screening Program," and the "National Cervical Screening Program." Therefore, there is a crucial requirement for a well-structured program such as a community-based program or a shared, informed decision-making program between clinicians and potential participants; accredited reporting centers; and a central data registry for quality control, monitoring, and outcome reporting. Additionally, integrated smoking cessation intervention, international data supporting cost-effectiveness, additional mortality benefits, and a high sustainability rate are a few factors that must be studied for lung cancer screening. Further, the International Association for the Study of Lung Cancer (IASLC) recommends implementing feasibility screening programs in the country without participating in lung cancer screening studies. These programs involve smoking cessation initiatives, standardized algorithms for selecting and managing screening participants, and specialist multidisciplinary teams to manage participants with positive screening results. Therefore, the implementation of structured lung cancer screening programs in the country is expected to be a lucrative opportunity in the Australia lung cancer screening market during the forecast period.
Australia Lung Cancer Screening Market - Test Type Insights
Based on cancer type, the Australia lung cancer screening market is bifurcated into NSCLC and small cell lung cancer. The NSCLC segment accounted for the largest market share in 2022 and is expected to grow at a CAGR of 10.3% during the forecast period. The market position of this segment is due to the rising cases of NSCLC in Australia. NSCLC develops more slowly than small cell lung cancer. It usually spreads to other parts of the patient's body by the time it is diagnosed. Therefore, early diagnosis and treatment are crucial. According to National Foundation for Cancer Research, NSCLC accounts for nearly 9 out of every 10 diagnoses. As per the same source, large-cell undifferentiated carcinoma lung cancer accounts for approximately 10-15% of all NSCLC diagnoses.
Based on technology, the Australia lung cancer screening market is segmented into LDCT, chest X-ray, liquid biopsy, and others. The chest X-ray segment accounted for the largest market share in 2022, however, the LDCT is expected to grow at a CAGR of 11.9% during the forecast period.
Based on age group, the Australia lung cancer screening market is bifurcated into 50 & older and below 50. The 50 & older segment accounted for the largest market share in 2022, however, the below 50 is expected to grow at a CAGR of 11.3% during the forecast period.
Based on end user, the Australia lung cancer screening market is segmented into hospitals, diagnostic centers, and others. The hospitals segment accounted for the largest market share in 2022, however, the others is expected to grow at a CAGR of 11.1% during the forecast period.
Australia Lung Cancer Screening Market - Recent Developments:
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the Australia lung cancer screening market. A few recent key market developments are listed below:
In June 2022, Royal Philips teamed up with Biodesix, Inc. to incorporate the results of Biodesix's Nodify Lung blood-based lung nodule risk assessment testing into Philips Lung Cancer Orchestrator lung cancer patient management system. The incorporation of proteomics data along with the radiologic and patient history data currently used to determine treatment decisions can help create diagnostic efficiency for cancer care centers in the management of a growing number of lung nodule cases via the contextual launch of Biodesix Nodify Lung application within Lung Cancer Orchestrator.
In August 2022, Intelerad Medical Systems acquired of PenRad Technologies, Inc., a software provider for enhancing breast imaging and lung screening productivity. The acquisition has expanded Intelerad's product offerings for mammography and lung analytics, optimizing workflow for radiologists and boosting patient health outcomes.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Australia Lung Cancer Screening Market - by Technology
1.3.2 Australia Lung Cancer Screening Market - by Cancer Type
1.3.3 Australia Lung Cancer Screening Market - by Age Group
1.3.4 Australia Lung Cancer Screening Market - by End User
2. Australia Lung Cancer Screening Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Australia Lung Cancer Screening Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert's Opinion
4.4 Demographics of Smoking, by Key States
4.5 Demographics of Smoking, by Income Bracket
4.6 Epidemiology of Lung Cancer in Australia
4.7 Patterns of Smoking in Australia
4.8 Trends Of Smoking in Australia
4.9 Regional Comparative Analysis of Smoking (Asian and European)
5. Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Lung Cancer
5.1.2 Rising Government Support
5.2 Market Restraints
5.2.1 Uncertainties Related to Lung Cancer Screening Trial with LDCT
5.3 Market Opportunities
5.3.1 Structured Lung Cancer Screening Program
5.4 Future Trends
5.4.1 Mobile Lung Cancer Screening Truck
5.5 Impact Analysis
6. Lung Cancer Screening Market - Australia Analysis
6.1 Australia Lung Cancer Screening Market Revenue Forecast and Analysis
7. Australia Lung Cancer Screening Market Analysis - by Cancer Type
7.1 Overview
7.2 Australia Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Thousand)
7.3 Non-Small Cell Lung Cancer (NSCLC)
7.3.1 Overview
7.3.2 Non-small cell lung cancer (NSCLC): Australia Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Thousand)
7.4 Small Cell Lung Cancer
7.4.1 Overview
7.4.2 Small Cell Lung Cancer: Australia Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Thousand)
8. Australia Lung Cancer Screening Market Analysis - by Technology
8.1 Overview
8.2 Australia Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Thousand)
8.3 Low-Dose Computed Tomography (LDCT)
8.3.1 Overview
8.3.2 Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Thousand)
8.4 Chest X-ray
8.4.1 Overview
8.4.2 Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Thousand)
8.5 Liquid Biopsy
8.5.1 Overview
8.5.2 Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Thousand)
8.6 Others
8.6.1 Overview
8.6.2 Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Thousand)
9. Australia Lung Cancer Screening Market Analysis - by Age Group
9.1 Overview
9.2 Australia Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Thousand)
9.3 & Older
9.3.1 Overview
9.3.2 & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
9.4 Below 50
9.4.1 Overview
9.4.2 Below 50: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
10. Australia Lung Cancer Screening Market Analysis - by End User
10.1 Overview
10.2 Australia Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Thousand)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
10.4 Diagnostic Centers
10.4.1 Overview
10.4.2 Diagnostic Centers: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
10.5 Others
10.5.1 Overview
10.5.2 Others: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
11. Australia Lung Cancer Screening Market: Impact Assessment of COVID-19 Pandemic
11.1 Impact Analysis of COVID-19 Pandemic on Australia Lung Cancer Screening Market
12. Australia Lung Cancer Screening Market-Industry Landscape
12.1 Recent Growth Strategies
12.1.1 Overview
13. Company Profiles
13.1 Intelerad Medical Systems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Nuance Communications Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE HealthCare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Medtronic
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Canon Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Koninklijke Philips NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 CVS Health
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 bioAffinity Technologies, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 LungLife AI, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Lung Screen Australia Pty Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Australia Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 2. Australia Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Thousand)
Table 3. Australia Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Thousand)
Table 4. Australia Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Thousand)
Table 5. Recent Growth Strategies in the Australia Lung Cancer Screening Market
Table 6. Glossary of Terms
LIST OF FIGURES
Figure 1. Australia Lung Cancer Screening Market Segmentation
Figure 2. Australia Lung Cancer Screening Market Overview
Figure 3. Non-Small Cell Lung Cancer Segment Held Largest Share Under Cancer Type Segment in Australia Lung Cancer Screening Market
Figure 4. Experts' Opinion
Figure 5. Australia Lung Cancer Screening Market: Impact Analysis of Drivers and Restraints
Figure 6. Australia Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020- 2030
Figure 7. Market Positioning of Key Players in Australia Lung Cancer Screening Market
Figure 8. Australia Lung Cancer Screening Market, by Cancer Type, 2022 & 2030 (%)
Figure 9. Non-Small Cell Lung Cancer (NSCLC): Australia Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. Small Cell Lung Cancer: Australia Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 11. Australia Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 12. Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Thousand)
Figure 14. Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Thousand)
Figure 16. Australia Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 17. & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 18. Below 50: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 19. Australia Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 20. Hospitals: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Diagnostic Centers: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 22. Others: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 23. Pre and Post COVID-19 Pandemic Impact in the Australia Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security